STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
25 hedge funds and large institutions have $645K invested in Statera Biopharma, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$34.7K | |
| 2 | +$16.5K | |
| 3 | +$10K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.36K |
Top Sellers
| 1 | -$37.1K | |
| 2 | -$8K | |
| 3 | -$3.72K | |
| 4 |
WA
Winfield Associates
Cleveland,
Ohio
|
-$1.14K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$381 |